| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.22 | 0.2 |